1. A Phase II Study of a Dose-Density Regimen With Fluorouracil, Epirubicin, and Cyclophosphamide on Days 1 and 4 Every 14 Days With Filgrastim Support Followed by Weekly Paclitaxel in Women With Primary Breast Cancer. (30th January 2015) Authors: Pietri, Elisabetta; Andreis, Daniele; Fabbri, Francesca; Menna, Cecilia; Schirone, Alessio; Kopf, Barbara; Rocca, Andrea; Amadori, Dino; De Giorgi, Ugo Journal: Oncologist Issue: Volume 20:Number 3(2015) Page Start: 239 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Phase II Study of a Dose‐Density Regimen With Fluorouracil, Epirubicin, and Cyclophosphamide on Days 1 and 4 Every 14 Days With Filgrastim Support Followed by Weekly Paclitaxel in Women With Primary Breast Cancer. (30th January 2015) Authors: Pietri, Elisabetta; Andreis, Daniele; Fabbri, Francesca; Menna, Cecilia; Schirone, Alessio; Kopf, Barbara; Rocca, Andrea; Amadori, Dino; De Giorgi, Ugo Journal: Oncologist Issue: Volume 20:Number 3(2015) Page Start: 239 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Aggressive lymphomas of the elderly: the DEVEC metronomic chemotherapy schedule fits the unfit. (28th November 2017) Authors: Cox, Maria Christina; Musuraca, Gerardo; Battistini, Roberta; Casaroli, Ivana; Zoli, Valerio; Anticoli‐Borza, Paola; Arcari, Annalisa; Naso, Virginia; di Landro, Francesca; Fabbri, Francesca; Tafuri, Agostino; Bocci, Guido; Merli, Francesco Journal: British journal of haematology Issue: Volume 183:Number 5(2018) Page Start: 819 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Baseline total metabolic tumour volume on 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography-computed tomography as a promising biomarker in patients with advanced non–small cell lung cancer treated with first-line pembrolizumab. (June 2021) Authors: Dall'Olio, Filippo G.; Calabrò, Diletta; Conci, Nicole; Argalia, Giulia; Marchese, Paola Valeria; Fabbri, Francesca; Fragomeno, Benedetta; Ricci, Dalia; Fanti, Stefano; Ambrosini, Valentina; Ardizzoni, Andrea Journal: European journal of cancer Issue: Volume 150(2021) Page Start: 99 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. How Many Cancer Clinical Trials Can a Clinical Research Coordinator Manage? The Clinical Research Coordinator Workload Assessment Tool. Issue 1 (16th January 2021) Authors: Fabbri, Francesca; Gentili, Giorgia; Serra, Patrizia; Vertogen, Bernadette; Andreis, Daniele; Dall'Agata, Monia; Fabbri, Greta; Gallà, Valentina; Massa, Ilaria; Montanari, Emanuela; Monti, Manuela; Pagan, Flavia; Piancastelli, Alessandra; Ragazzini, Angela; Rudnas, Britt; Testoni, Sara; Valmorri,... Journal: JCO oncology practice Issue: Volume 17:Issue 1(2021) Page Start: e68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. The Use of Antigenic SARS-CoV-2 Point-of-Care Test: The Italian Pediatric Real-Life Experience. (January 2022) Authors: Ferrari, Federica; Civitelli, Fortunata; Ardenti Morini, Francesca; Buonaiuto, Federico Angelo Carmelo; Frega, Gianluca; Fabbri, Francesca; Ioppi, Mauro; Maione, Alberto; Minniti De Simeonibus, Elena; Soscia, Francesca; Torre, Piera; Toselli, Francesca; Cortis, Elisabetta Journal: Clinical pediatrics Issue: Volume 61:Number 1(2022) Page Start: 34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. What Explains the Rise in Executive Pay in Germany? A Panel Data Analysis for 1977–20091. (3rd December 2015) Authors: Fabbri, Francesca; Marin, Dalia Journal: Scandinavian journal of economics Issue: Volume 118:Number 2(2016:Jun.) Page Start: 235 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗